S215: GEMSTONE-201: PRE-PLANNED PRIMARY ANALYSIS OF A MULTICENTER, SINGLE-ARM, PHASE 2 STUDY OF SUGEMALIMAB IN PATIENTS WITH RELAPSED OR REFRACTORY EXTRANODAL NATURAL KILLER/T CELL LYMPHOMA (R/R ENKTL)

oleh: H. Huang, R. Tao, Y. Yang, H. Cen, H. Zhou, Y. Guo, L Zou, J. Cao, Y. Huang, J. Jin, L. Zhang, H. Yang, X. Xing, H. Zhang, Y. Liu, K. Ding, X. Zhu, T. Fang, H. Dai, Q. Qi, J. Yang